Fibrosis Unknown Status Phase 1 / 2 Trials for Ursodeoxycholic acid (DB01586)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01483248Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver CirrhosisTreatment